A Rating Scale for Psychotic Symptoms (RSPS): Part II: Subscale 2: Distraction symptoms (catatonia and passivity experiences); Subscale 3: Delusions and semi-structured interview (SSCI-RSPS)

Schizophrenia Research

Volumn 38, Issue 2-3, 1999, Pages 123-150

  Chouinard, Guy ^a,b,c   Miller, Robert ^d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^c Allan Memorial Institute   (Canada)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Delusion; Mania; Passivity experience; Positive symptom; Psychosis; Rating scale; Schizoaffective disorder; Schizophrenia; Selective attention

Indexed keywords

ATTENTION; CATATONIA; DELUSION; HALLUCINATION; HUMAN; MENTAL PERFORMANCE; MOVEMENT (PHYSIOLOGY); NEUROTRANSMISSION; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; RECUMBENCY; REVIEW; SYMPTOMATOLOGY; THINKING;

EID: 0032769916     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(99)00013-4     Document Type: Article

References (16)

1. Baruch I., Hemsley D.R., Gray J.A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J. Nerv. Ment. Dis. 176:1988;598-606.
2. Chapman L.J., Chapman J.P. The genesis of delusions. Oltmanns T.F., Maher B.A. Delusional Belief. 1985;167-183 Wiley Interscience, New York.
3. Chouinard G., Ross-Chouinard A., Annable L., Jones B.D. The extrapyramidal symptom rating scale. Can. J. Neurol. 7:1980;233.
4. Cornblatt B.A., Lenzenwegar M.F., Dworkin R.H., Erlenmeyer-Kimling L. Positive and negative schizophrenic symptoms, attention and information processing. Schizophr. Bull. 11:1985;397-407.
5. Fenton W.S., McGlashan T.H. The prognostic significance of obsessive compulsive symptoms in schizophrenia. Am. J. Psychiatr. 143:1986;437-441.
6. Flor-Henry P. Laterality and motility disturbances in psychopathology: a theoretical perspective. Joseph A.B., Young R.R. Movement Disorders in Neurology and Neuropsychiatry. 2nd Edition :1999;304-310 Blackwell Scientific, Boston, MA.
7. Killcross A.S., Everitt B.J., Robins T.W. Symmetrical effects of amphetamine and alpha-flupenthixol on conditioned punishment and conditioned reinforcement: contrasts with midazolam. Psychopharmacology. 129:1997;141-152.
8. Koles Z.J., Lind J., Flor-Henry P. Spatial patterns in the background EEG underlying mental disease in man. Electroencephalogr. Clin. Neurophysiol. 91:1994;319-328.
9. Kornetsky C. The use of a simple test of attention as a measure of drug affects in schizophrenic patients. Psychopharmacologia. 24:1972;99-106.
10. Maloney M.P., Sloane R.D., Whipple K., Rzani J., Eaton E.M. Auditory attention in process and reactive schizophrenia. Biol. Psychiatry. 11:1976;325-332.
11. Miller R., Wickens J.R. Cortico-striatal cell assemblies in selective attention and in representation of predictable and controllable events. A general statement of corticostriatal interplay and the role of striatal dopamine. Concepts Neurosci. 2:1991;65-95.
12. Miller R. Striatal dopamine in reward and attention: a system for understanding the symptomatology of acute schizophrenia and mania. Int. Rev. Neurobiol. 35:1993;161-278.
13. Oltmanns T.F., Ohayon J., Neale J.M. The effect of antipsychotic medication and diagnostic criteria on distractibility in schizophrenia. J. Psychiatr. Res. 14:1978;81-91.
14. Orzack M.H., Kornetsky C., Freeman M. The effects of daily administration of carphenazine on attention in the schizophrenic patient. Psychopharmacologia. 11:1967;31-38.
15. Rockland L.H. Neuroleptic blood levels and clinical response. Can. J. Psychiatry. 31:1986;299-303.
16. Van Putten T., Marder S.R., Mintz J., Poland R.E. Haloperidol plasma levels and clinical response: a therapeutic window relationship. Am. J. Psychiatry. 149:1992;500-505.